Pheochromocytoma: Issues in diagnosis and treatment

Comprehensive Therapy

Volumn 23, Issue 5, 1997, Pages 319-326

  Young Jr , William F ^a,b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXAZOSIN; ESMOLOL; LIDOCAINE; METADRENALIN; METIROSINE; METOPROLOL; NADOLOL; NITROPRUSSIDE SODIUM; PHENOXYBENZAMINE; PHENTOLAMINE; PRAZOSIN; PROPRANOLOL; TERAZOSIN; VANILMANDELIC ACID; VINCRISTINE;

CARDIOVASCULAR DISEASE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; GALACTORRHEA; GASTROINTESTINAL TOXICITY; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PHEOCHROMOCYTOMA; PREGNANCY; REVIEW; SOMNOLENCE; SYMPTOMATOLOGY; UROLITHIASIS;

ADULT; ALGORITHMS; BIOLOGICAL MARKERS; CATECHOLAMINES; FEMALE; HUMANS; KIDNEY FAILURE; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC;

EID: 1842375671     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Stenstrom G, Svardsudd K. Phaechromocytoma in Sweden. 1958-81: an analysis of the National Cancer Registry Data. Acta Med Scand. 1986;220(suppl):225-232.
2. Ito Y, Fujimoto Y, Obara T. The role of epinephrine, norepinephrine, and dopamine in blood pressure disturbances in patients with pheochromocytomas. World J Surg. 1992;16:759-764.
3. Young WF Jr, Maddox DE. Spells: in search of a cause. Mayo Clin Proc. 1995;70:757-765.
4. Manger WM, Gifford RW Jr. Pheochromocytoma. New York, NY: Springer-Verlag; 1977.
5. Young WF Jr. Phaeochromocytoma: how to catch a moonbeam in you hand. Europ J Endocrinol. 1997;136:28-29.
6. Young WF Jr. Pheochromocytoma: 1926-1993. Trends in Endocrinol Metab. 1993;4:122-127.
7. Sheps SG, Jiang N-S, Klee GG. Diagnostic evaluation of pheochromocytoma. Endocrinol Metab Clin. 1988;17:397-414.
8. Boomsma F, Bhaggoe UM, Man in 't Veld AJ, Schalekamp MADH. Sensitivity and specificity of a new ELISA method for determination of chromogranin A in the diagnosis of pheochromocytoma and neuroblastoma. Clinica Chimica Acta. 1995;239:57-63.
9. Canale MP, Bravo EL. Diagnostic specificity of serum chromogranin-A for pheochromocytoma in patients with renal dysfunction. J Clin Endocrinol Metab. 1994;78:1139-1144.
10. Lenders JWM, Keiser HR, Goldstein DS, et al. Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Intern Med. 1995;123:101-109.
11. Stein PP, Black HR. A simplified diagnostic approach to pheochromocytoma: a review of the literature and report of one institution's experience. Medicine. 1991;70:46-66.
12. Chauveau D, Martinez F, Houhou S, et al. Malignant hypertension secondary to pheochromocytoma in a hemodialyzed patient. Am J Kidney Diseases. 1993;21:52-55.
13. Stumvoll M, Radjaipour M, Seif F. Diagnostic considerations in pheochromocytoma and chronic hemodialysis: case report and review of the literature. Am J Nephrol 1995;15:147-151.
14. Jackson JA, Kleerekoper M, Mendlovic D. Endocrine grand rounds: a 51-year-old man with accelerated hypertension, hypercalcemia, and right adrenal and paratracheal masses. Endocrinologist. 1993;3:5-13.
15. van Gils APG, Falke THM, van Erkel AR, et al. MR imaging and MIBG scintigraphy of pheochromocytomas and extraadrenal functioning paragangliomas. Radiograph. 1991;11:37-57.
16. Whalen RK, Althausen AF, Daniels GH. Extra-adrenal pheochromocytoma. J Urol. 1992;147:1-10.
17. O'Riordain DS, Young WF Jr, Grant CS, Carney JA, van Heerden JA. Clinical spectrum and outcome of functional extraadrenal paraganglioma. World J Surg. 1996;20:916-922.
18. Shapiro B, Gross MD, Fig L, Khafagi F. Localization of functioning sympathoadrenal lesions. In: Biglieri EG, Melby JC, eds. Endocrine Hypertension. New York, NY: Raven Press LTD; 1990;235.
19. Tenenbaum F, Lumbroso J, Schlumberger M, et al. Comparison of radiolabeled octreotide and metaiodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma. J Nucl Med. 1995;36:1-6.
20. Shulkin BL, Wieland DM, Schwaiger M, et al. PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma. J Nucl Med. 1992;33:1125-1131.
21. Platts JK, Drew PJT, Harvey JN. Death from phaeochromocytoma: lessons from a postmortem survey. J Royal College Physicians London. 1995;29:299-306.
22. Gagner M, Lacroix A, Bolte E. Laparoscopic adrenalectomy in Cushing's syndrome and pheochromocytoma. N Engl J Med. 1992;327:1033.
23. Jeevanandam V, Oz MC, Shapiro B, et al. Surgical management of cardiac pheochromocytoma: resection versus transplantation. Ann Surg. 1995;221:415-419.
24. Nativ O, Grant CS, Sheps SG, et al. The clinical significance of nuclear DNA ploidy pattern in 184 patients with pheochromocytoma. Cancer. 1992;69:2683-2687.
25. Eng C, Clayton D, Schuffenecker I, et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET Mutation Consortium Analysis. JAMA. 1996:276:1575-1579.
26. Krempf M, Lumbroso J, Mornex R. Use of m-[131-I]iodobenzylguanidine in the treatment of malignant pheochromocytoma. J Clin Endocrinol Metab. 1991;72:455-461.
27. Shapiro B, Sisson JC, Wieland DM, et al. Radiopharmaceutical therapy of malignant pheochromocytoma with [131-I]-metaiodobenzylguanidine: results from ten years of experience. J Nucl Biol Med. 1991;35:269-276.
28. Averbuch SD, Steakley CS, Young RC, et al. Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Ann Intern Med. 1988;109:267-273.